LAUSR

evaluated in patients treated in ONCOSALUD—AUNA between 2000 and 2005 (n = 114). The incidence rate was calculated based on new cases/persons‐year of observation. The OS was calculated according to Kaplan‐Meier method. Results: The median age was 33 years, and 55.7% were women. A total of 2,611,438.3 persons‐year of observation was produced, and 284 affiliates were diagnosed with NHL. The median age at diagnosis was 65 years. The standardized incidence rate by age was 6.4 per 100,000 persons‐year (5.6 and 7.8 in women and men per 100,000 persons‐year, respectively), and 74 years cumulative risk was 0.7% (0.6 and 0.9% in women and men, respectively). For survival assessment, the median age was 63 years, 52.6% were women and 48.0% had advanced disease (CS III: 14.0% and CS IV: 34.0%). With a 11.3‐ year follow‐up, the median survival was not achieved. The OS rate at 5 and 10 years were 56.8% and 52.1%, not showing significant difference in relation to sex (p = 0.107, although female patients had a better survival), and shows significant difference according age (<60 vs. >60 years: p < 0.001) and clinical stage (CS I‐II vs. III–IV: p = 0.008). Conclusions: The incidence rate of NHL in our population is similar than reported by the IARC for the Peruvian population. The survival rate at 5 and 10 years is similar to reported for other series.